Back to Resources

If you sell pet food, treats, or supplements on Amazon, you’ve probably had a listing flagged for a claim violation at least once. Maybe you didn’t see it coming. Maybe the listing had been live for a year before Amazon’s enforcement caught up with it.

What surprises most pet brands isn’t that the restrictions exist. They know claims are regulated. What surprises them is how broad the restrictions actually are, and how much enforcement has tightened since 2024. The FDA issued a formal warning letter to Amazon in March 2025 regarding unapproved drug products distributed through FBA. That letter accelerated scrutiny that was already increasing.

The brands navigating this well have found ways to write listing copy that converts without leaning on the claims that would get them flagged. That’s the part worth understanding.

What Amazon Actually Prohibits

Amazon’s policy mirrors FDA guidance: any language that implies a product can diagnose, cure, mitigate, treat, or prevent a disease in humans or animals is prohibited. This applies to all placement — listing titles, bullet points, descriptions, back-end keywords, A+ Content, and product names. Getting it off the bullets and into the A+ module doesn’t protect you.

The policy covers both explicit disease claims and implied ones. A statement doesn’t need to name a disease to be a violation. If the language clearly implies a therapeutic effect, Amazon treats it as a disease claim.

Some examples of where the line sits in practice:

Allowed (structure/function claims):

• “Supports joint health and mobility”
• “Promotes healthy skin and coat”
• “Helps maintain urinary tract health”
• “Supports cognitive function in aging dogs”

Prohibited (disease claims):

• “Reduces the pain and stiffness associated with arthritis”
• “Clinically proven to treat hip dysplasia”
• “Relieves symptoms of kidney disease”
• “Helps dogs recover from surgery”

The practical test: if your claim describes what a healthy body function looks like, it’s likely allowed. If it references a named condition, a disease process, or implies treatment or relief of symptoms, it’s a violation.

Terms like “treats,” “cures,” “FDA approved,” and “prescription-strength” are explicitly off the table. So is any language suggesting your product produces effects similar to a drug or as an alternative to veterinary care.

One thing worth knowing: listings that have been live for years are not immune. Amazon’s enforcement has become more active, and a listing that passed review eighteen months ago may not pass review today.

The Compliance Baseline Most Pet Brands Are Behind On

Amazon’s third-party verification requirements for supplements have expanded significantly over the past two years, and pet supplement brands need to understand where things currently stand.

The process started in April 2024 with a policy targeting high-risk supplement categories: sexual enhancement, weight management, sports nutrition, bodybuilding, and joint health. Those categories now require product testing verification through Amazon’s approved third-party Testing, Inspection, and Certification (TIC) providers — NSF International, Eurofins, and UL Solutions — via the Manage Your Compliance dashboard. Direct COA submissions are no longer accepted.

In late 2025, Amazon announced an expansion of these requirements to all dietary supplement categories, including pet supplements outside the original high-risk list. This newer rollout adds a cGMP facility compliance requirement — proof that your manufacturing facility meets FDA current Good Manufacturing Practice standards, verified by an Amazon-approved TIC. Amazon is contacting affected sellers in phases, and companies typically have 90 days from outreach to initiate a documentation request.

If your pet supplement products haven’t shown up on your Manage Your Compliance dashboard yet, that doesn’t mean they’re permanently exempt. The rollout is ongoing.

For joint health supplements specifically, additional adulterant screening under NSF/ANSI 173-2024 applies — worth flagging because joint support is one of the highest-revenue subcategories in pet supplements and one of the first areas Amazon scrutinized.

COAs must come from ISO/IEC 17025-accredited labs and need to be renewed every 9-12 months. A lapsed certificate can result in listing suppression, and suppression doesn’t come with much warning. Building a compliance calendar — tracking when each product’s certification expires and when to initiate renewal — is operational work now, not a one-time setup.

Writing Conversion Copy Under Restrictions

Here’s what the restrictions actually create: a category where most compliant copy is also dull. 

Brands that discover they can’t say what they want to say tend to default to the most generic version of what they can say. “Supports joint health” appears on roughly every fourth pet supplement listing. It says nothing that distinguishes the product.

The sellers doing the best work under these constraints aren’t trying to find a workaround. They’re finding a different angle entirely.

Ingredient specificity

When you can’t make outcome claims, the ingredients themselves become the message. Sourcing details, form factors, and potency can carry real weight with informed buyers. “1,000mg of glucosamine HCl per chew, sourced from non-shellfish fermentation for dogs with seafood sensitivities” communicates more to the right buyer than any benefit claim would.

Transparency as positioning

Third-party testing certifications, manufacturing standards, and quality documentation have shifted from backstory to selling point. A buyer choosing between two joint support chews with similar ingredient panels will often move toward the one that makes its testing and quality standards visible. This is especially true in the post-2024 compliance environment, where the TIC requirements have differentiated brands that take documentation seriously from those that don’t.

Identity-based copy

Pet supplement buyers are not buying for themselves. They’re buying for an animal they feel responsible for, often one with a specific life stage, breed, or health history in mind. Copy that speaks to a 9-year-old Labrador with slowing mobility, or a cat who stopped eating well after moving to a new home, engages a buyer’s actual situation without making any claims about disease or treatment.

Format and convenience

How the product is delivered — chew vs. powder vs. liquid, palatability, ease of administration, consistency of dose — is fair game and often underused in copy. Buyers who’ve struggled to get a supplement into a reluctant dog or a suspicious cat will respond to specifics here.

What A+ Content Can Actually Do

A+ Content carries the same claim restrictions as your main listing. Disease claims don’t become allowed because they appear in a premium module.

What A+ does offer is space — more room to tell the ingredient story, show sourcing and manufacturing detail, build a comparison chart, and use imagery to reinforce quality signals. Brands that treat A+ as a second chance to say what the listing copy couldn’t are going to run into the same compliance issues. Brands that use it to deepen the case for a product that the listing copy has already introduced tend to see better results.

A few things that work well in pet supplement A+ specifically:

A comparison chart showing your product against a category-generic version can highlight the gaps — ingredient quality, third-party testing, form factor — without making any prohibited claims. Buyers doing comparison shopping respond to this if the comparison is honest.

Ingredient origin stories and manufacturing process details occupy space that might otherwise be filled with benefit language. A buyer who understands where your glucosamine comes from and how the product is tested has more reason to trust it than a buyer who’s read a list of benefits that every competitor is also claiming.

Lifestyle imagery tied to specific life stages or breeds creates identification without making claims. A senior dog doing what senior dogs do — slower, but comfortable, present — communicates something to the right buyer without saying anything about what the product does.

Building a Compliance Review Process

The brands that get tripped up most often are the ones treating compliance as a launch checklist rather than an ongoing practice. Listings get updated. Copy gets refreshed. New team members write bullets. Each of those moments is a potential reintroduction of language that shouldn’t be there.

A few things worth having in place:

A claim review at every copy update. Anyone touching listing copy, A+ content, or back-end keywords should be reviewing against the disease claim standard before publishing. This doesn’t require a legal team — it requires a clear internal reference of what’s allowed and what isn’t, and a habit of checking.

A compliance calendar for documentation. Track each ASIN’s TIC certification date and the renewal window. Twelve months goes faster than it seems when you’re managing a catalog, and a suppressed listing during a peak period is an expensive lesson.

A pre-launch review for new products. Run new ASINs against claim guidelines before they go live, not after they get flagged. Catching violations internally first is substantially less disruptive than appealing a suppression after launch.

Product naming review. Product names are part of the listing and subject to the same restrictions. A name that implies a therapeutic effect — something like “ArthriRelief Chews” or “Anxiety Calm Bites” — can trigger a violation independent of anything in the copy.

The goal is to operate cleanly enough that compliance is never the reason a listing goes down.

How Canopy Management Can Help

Ready to partner with a team that has the systems and expertise to scale your brand?

Canopy Management delivers end-to-end eCommerce growth, leading the industry in Amazon marketplace strategy while powering expansion through Shopify, Meta, and Google. Our full-funnel approach — from marketplace optimization to customer acquisition — has generated over $3.3 billion in partner revenue and made us the trusted growth engine for brands worldwide.

Schedule a strategy session with our team to discover exactly how our proven frameworks can accelerate your growth.

FAQ